$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
肺癌靶向治疗药爱必妥上市了吗
2025-10-19 11:44:20
Check Details
爱必妥对直肠结肠癌有特效吗
2025-10-19 11:44:20
Check Details
结肠癌发生的重要因素可能是炎症小体
2025-10-19 11:44:20
Check Details
早发的结直肠癌比晚发的更严重,早期结肠直肠癌上升因素有哪些
2025-10-19 11:44:20
Check Details
西妥昔单抗加多少盐水?西妥昔单抗注射液用法用量及注意事项是什么?
2025-10-19 11:44:20
Check Details
14天一疗程?西妥昔单抗怎么算疗程?西妥昔单抗一般用几个疗程?
2025-10-19 11:44:20
Check Details
西妥昔单抗在医保范围内吗?西妥昔单抗注射液2021年最新报销政策是怎样的?
2025-10-19 11:44:20
Check Details
西妥昔单抗一支价格多少?西妥昔单抗注射液医保可报销多少?
2025-10-19 11:44:20
Check Details
西妥昔单抗国内怎么买?西妥昔单抗2021最新医保价格
2025-10-19 11:44:20
Check Details
西妥昔单抗多久打一针?西妥昔单抗怎么算疗程?
2025-10-19 11:44:20
Check Details
西妥昔单抗多少钱一支?西妥昔单抗2021年在医保报销范围内吗?
2025-10-19 11:44:20
Check Details
服用瑞格菲尼的作用大吗?吃瑞格非尼能多活5年吗?
2025-10-19 11:44:20
Check Details
1
2
...
7701
7702
7703
7704
7705
7706
7707
...
10233
10234
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Hibsago (Bepirovirsen) Japan Approval: CHB Functional Cure and B-Well Data Essentials
2
FDA Approves Isembyld (apitegromab-mstn), the World’s First Skeletal Muscle-Targeted Therapy for SMA
3
Post-Enzalutamide mCRPC: HRR/PARP, PSMA Radioligand, and Chemotherapy Sequencing
4
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
5
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
6
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
7
Bedaquiline for Drug-Resistant TB: 24-Week Regimen, Combination Duration, and When to Stop or Extend
8
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments
9
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
10
Bosutinib for Ph+ CML: Indications, Dosing Adjustments, and Hepatic/Renal Safety
11
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
12
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance